Glenmark Pharmaceuticals Share price target & analyst calls

₹2,166.6-31.90 (-1.45%)
As of 23 Oct 2026

Avg 1-year target

4 of 5 long-term calls BUY

₹2,347.58.3% above today's price

Glenmark Pharmaceuticals' average 1-year share price target is ₹2,347.5, the average of 4 advisors' latest targets. Targets range from ₹1,640 to ₹2,590.

Latest: Jefferies India ₹2,590 · 4 Aug 2026

8
7 BUY · 1 SELL, all horizons
4
with an active 1Y target
32%
24 of 76 closed calls hit
85
all horizons, open and closed

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips · page 2 of 2

← Back to filtered view
BUYTarget₹2,420
1–2 Weeks* · 30 Jul 2026 · entry ₹2,261.7 · via Business Standard Marketsexit ₹2,180
BUYTarget₹2,300
PGbyPrakash GabaStop-loss hit
1–2 Weeks* · 6 Jul 2026 · entry ₹2,268 · via CNBC Awaaz.exit ₹2,240
BUYTarget₹2,300
1–2 Weeks* · 23 Jun 2026 · entry ₹2,221.2 · via CNBC Awaaz.exit ₹2,160
BUYTarget₹2,580
1–2 Weeks* · 20 May 2026 · entry ₹2,370 · via ET Nowexit ₹2,290
BUYTarget₹2,600
1–2 Weeks* · 18 May 2026 · entry ₹2,339.9 · via Business Todayexit ₹2,200
BUYTarget₹2,350
1–2 Weeks* · 6 Aug 2026 · entry ₹2,270 · via Business Todayexit ₹2,246.5
BUYTarget₹2,350
1–2 Weeks* · 7 Jul 2026 · entry ₹2,270.9 · via NDTV Profit (Live)exit ₹2,239.6
BUYTarget₹2,340
1–2 Weeks* · 6 Jul 2026 · entry ₹2,260.7 · via Business Todayexit ₹2,233.8
BUYTarget₹2,290
1–2 Weeks* · 9 Jun 2026 · entry ₹2,209.6 · via CNBC Awaaz.exit ₹2,192
BUYTarget₹2,500
1–2 Weeks* · 5 May 2026 · entry ₹2,375 · via CNBC Awaaz.exit ₹2,343
BUYTarget₹2,475
1–2 Weeks* · 23 Apr 2026 · entry ₹2,300 · via ET Nowexit ₹2,365.5
BUYTarget₹2,340
RSbyRajesh SatputeStop-loss hit
BTST · 7 Aug 2026 · entry ₹2,274.9 · via CNBC Awaaz.exit ₹2,270
BUYTarget₹2,400
BTST* · 20 Aug 2026 · entry ₹2,333.1 · via NDTV Profitexit ₹2,311.2
BUYTarget₹2,310
BTST · 9 Jul 2026 · entry ₹2,267.2 · via CNBC Awaaz.exit ₹2,283.4
BUYTarget₹2,350
PRbyPankaj Randad○ No trade
BTST* · 9 Jun 2026 · entry ₹2,283 · via CNBC Awaaz.
BUYTarget₹2,450
Intraday* · 26 Aug 2026 · entry ₹2,419 · via ET Nowexit ₹2,450
BUYTarget₹2,255
Intraday* · 29 Jul 2026 · entry ₹2,202.5 · via CNBC Awaaz.exit ₹2,255
BUYTarget₹2,300
PGbyPrakash GabaStop-loss hit
Intraday* · 21 Oct 2026 · entry ₹2,246 · via CNBC Awaaz.exit ₹2,230
BUYTarget₹2,320
PGbyPrakash GabaStop-loss hit
Intraday* · 12 Aug 2026 · entry ₹2,287.4 · via CNBC Awaaz.exit ₹2,280
BUYTarget₹2,340
PGbyPrakash GabaStop-loss hit
Intraday* · 7 Aug 2026 · entry ₹2,280.6 · via CNBC Awaaz.exit ₹2,280
BUYTarget₹2,250
Intraday* · 29 Jul 2026 · entry ₹2,210 · via CNBC Awaaz.exit ₹2,195
BUYTarget₹2,360
RSbyRajesh SatputeStop-loss hit
Intraday* · 13 Jul 2026 · entry ₹2,310 · via CNBC Awaaz.exit ₹2,270
BUYTarget₹2,350
ASbyAmit SethStop-loss hit
Intraday* · 7 Jul 2026 · entry ₹2,286 · via CNBC Awaaz.exit ₹2,250
BUYTarget₹2,320
RSbyRajesh SatputeStop-loss hit
Intraday · 7 Jul 2026 · entry ₹2,279.1 · via CNBC Awaaz.exit ₹2,260
BUYTarget₹2,260
RSbyRajesh SatputeStop-loss hit
Intraday* · 3 Jul 2026 · entry ₹2,219.5 · via CNBC Awaaz.exit ₹2,200
BUYTarget₹2,515
Intraday* · 22 Sept 2026 · entry ₹2,472 · via Zee Business (Live)exit ₹2,471.7
BUYTarget₹2,500
Intraday* · 8 Sept 2026 · entry ₹2,489.9 · via Business Todayexit ₹2,479
BUYTarget₹2,500
Intraday · 8 Sept 2026 · entry ₹2,469.9 · via Zee Business (Live)exit ₹2,479
BUYTarget₹2,509
Intraday* · 8 Sept 2026 · entry ₹2,469.9 · via Zee Business (Live)exit ₹2,479
BUYTarget₹2,550
Intraday* · 28 Aug 2026 · entry ₹2,493 · via CNBC Awaaz.exit ₹2,513.7
BUYTarget₹2,520
Intraday* · 27 Aug 2026 · entry ₹2,475.4 · via CNBC Awaaz.exit ₹2,458.9
BUYTarget₹2,500
Intraday* · 26 Aug 2026 · entry ₹2,433.3 · via CNBC Awaaz.exit ₹2,438.5
BUYTarget₹2,350
Intraday* · 13 Aug 2026 · entry ₹2,302.7 · via CNBC Awaaz.exit ₹2,318.5
BUYTarget₹2,300
Intraday* · 9 Jul 2026 · entry ₹2,249.9 · via CNBC Awaaz.exit ₹2,269.3
BUYTarget₹2,280
Intraday · 29 Jun 2026 · entry ₹2,193 · via Sahi Research Telegramexit ₹2,185.5

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks

Showing 51–85 of 85